CMS Finalises Increased Inpatient Reimbursement for WiSE

Key points

• CMS finalized increased inpatient reimbursement for WiSE System
• Base Medicare payment rates increased by approximately 58% and 93%
• Total Medicare payment may reach approximately US$77,839 and US$66,566
• Expected to support hospital adoption as EBR scales U.S. commercialisation

Full summary

EBR Systems, Inc. announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has finalized an increased Medicare inpatient reimbursement pathway for the WiSE System under the FY2027 Inpatient Prospective Payment System (IPPS) Final Rule. The final rule strengthens the reimbursement framework by reassigning eligible WiSE procedures to higher-value categories, aligning with leadless pacemaker procedures. The base payment rates for these procedures increased by approximately 58% and 93%, with potential total payments reaching approximately US$77,839 and US$66,566, respectively, when including the New Technology Add-on Payment (NTAP). This improved reimbursement is expected to reduce barriers for hospitals adopting the WiSE System as EBR scales its U.S. commercialization efforts.